Indigokarmin Serb (Indigo Carmine)

Indigo Carmine is a water‑soluble dye that circulates in the bloodstream after intravenous injection. It binds to plasma proteins and is filtered by the kidneys, imparting a blue coloration to vascular and urinary structures. This visual tracer enables clinicians to track fluid pathways and enhance contrast in imaging or surgical fields.

The exact dose of Indigokarmin Serb is determined by the prescribing clinician based on the specific diagnostic or surgical procedure, patient weight, and clinical condition. Healthcare professionals follow established guidelines and adjust the volume to achieve adequate visual contrast while maintaining safety.

Safety data for indigo carmine in pregnancy and lactation are limited. The product should be used only if clearly needed and after a risk‑benefit assessment by the prescriber. Women who are pregnant or breastfeeding should discuss potential risks with their healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details (including cold‑chain if required), and import documentation.

Indigo carmine provides a distinct blue coloration and is rapidly cleared by the kidneys, making it useful for short‑duration procedures. Compared with sodium fluorescein, which emits fluorescence, indigo carmine offers visible color contrast without special lighting. Choice of dye depends on the procedure, required imaging modality, and patient tolerance.

Indigokarmin Serb should be stored at 2‑8 °C in a refrigerator, protected from light, and never frozen. The vial must be kept in its original packaging to avoid moisture exposure. Before use, inspect for particulate matter or discoloration; do not shake the solution vigorously.

The product is supplied as a sterile solution for injection and is administered intravenously by a qualified healthcare professional. The injection is typically given as a bolus or slow infusion, depending on the clinical protocol, to achieve the desired level of tissue coloration.

Serious risks include anaphylactic reactions, severe hypotension, methemoglobinemia, cardiac arrhythmias, and acute renal dysfunction. Immediate medical intervention is required if any of these events occur. Monitoring of vital signs during and after administration is essential to detect adverse reactions promptly.

Patients with a known hypersensitivity to indigo carmine or any component of the formulation should not receive the product. Caution is also advised for individuals with severe cardiovascular instability, uncontrolled hypertension, or significant renal impairment, as they may be at higher risk for adverse effects.